Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses. (2025)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41564-025-01930-y
PubMed Identifier: 39929976
Publication URI: http://europepmc.org/abstract/MED/39929976
Type: Journal Article/Review
Volume: 10
Parent Publication: Nature microbiology
Issue: 3
ISSN: 2058-5276